semaglutide updates cagrilintide combination trial weight loss 2024 cagrisema phase 3 results 2025 vs Tirzepatide: 23% in in Medicine Cagrilintide and Semaglutide: CagriSema Weight – Medicare Update: New GLP-1 Program

E., & Rosenberg, I

GLP-1 receptor agonists like semaglutide have transformed weight loss treatment, but combining them with the wrong medications can undermine results or trigger safety concerns

Postmenopausal women face particularly high UTI risk because declining estrogen levels thin the vaginal and urethral tissues, reduce protective Lactobacillus populations, and alter urinary pH

They are known for their role in reducing oxidative damage and supporting overall cellular health

Many obese patients are denied surgery or experience poor recovery due to metabolic dysfunction, delayed wound healing, and elevated cardiopulmonary risk

Instead, it has other functions in the body